Nanobiotix S.A. (NNBXF)

9.10 0.00 (0.00%) At close: 03:47PM EDT

Nanobiotix S.A.

60 rue de Wattignies
Paris 75012
France
33 1 40 26 04 70
https://www.nanobiotix.com

Sector(s): 
Industry: 
Full-time employees: 100

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Laurent Levy Ph.D.	Co-Founder, Pres of the Exec. Board & CEO	532.46k	N/A	1973
Ms. Anne-Juliette Hermant M.A.	Chief People Officer & Member of Exec. Board	311.37k	N/A	1974
Prof. Para Prasad Ph.D.	Co-Founder and Member of Scientific Board	N/A	N/A	1945
Mr. Earl J. Bergey Ph.d.	Co-Founder	N/A	N/A	1955
Mr. Bart Van Rhijn	CFO & Member of Exec. Board	N/A	N/A	N/A
Mr. Alain Dostie	Chief Operating Officer	N/A	N/A	N/A
Ms. Kathryn M. McNeil	Sr. VP of Investor Relations	N/A	N/A	1975
Mr. Brandon Owens	VP of Strategic Marketing & Corp. Communication	N/A	N/A	N/A
Ms. Elsa Borghi	Head of Innovation & Drug Discovery	N/A	N/A	N/A
Ms. Sarah Gaubert	Head of Communication & Public Affairs Department	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.

Corporate governance

Nanobiotix S.A.’s ISS governance QualityScore as of 1 May 2022 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 9; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.